Litcius/Paper detail

Synergistic strategies for enhanced liver cancer therapy with sorafenib/resveratrol PEGylated liposomes in vitro and in vivo

Amal Abdullah Alrashidi, Seyed Zeinab Alavi, Seyed Zeinab Alavi, Maedeh Koohi Moftakhari Esfahani, Aun Raza, Bandar Almutairy, Sitah Alharthi, Hasan Ebrahimi Shahmabadi, Seyed Ebrahim Alavi, Seyed Ebrahim Alavi

2024Journal of Drug Delivery Science and Technology19 citationsDOI

Topics & Concepts

PEGylationIn vivoSorafenibPharmacologyChemistryResveratrolPEG ratioIn vitroLiposomeCytotoxicityCancer cellBiochemistryCancerPolyethylene glycolMedicineCancer researchBiologyInternal medicineHepatocellular carcinomaEconomicsBiotechnologyFinanceNanoparticle-Based Drug DeliveryRNA Interference and Gene DeliveryNanoplatforms for cancer theranostics
Synergistic strategies for enhanced liver cancer therapy with sorafenib/resveratrol PEGylated liposomes in vitro and in vivo | Litcius